Creative Planning Compugen LTD Transaction History

Creative Planning

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$4.09 - $7.16 $252,925 - $442,774	-61,840 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$5.8 - $8.02 $243,600 - $336,840	-42,000 Reduced 40.45%	61,840 $369,000
Q2 2021 Aug 04, 2021	BUY	$6.87 - $9.16 $713,380 - $951,174	103,840 New	103,840 $860,000
Q4 2017 Jan 17, 2018	SELL	$2.35 - $4.0 $23,951 - $40,768	-10,192 Closed	0 $0
Q3 2017 Oct 17, 2017	BUY	$2.75 - $3.95 $28,028 - $40,258	10,192	10,192 $39,000

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $131M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.